No abstract available
Keywords:
EML4-ALK; EML4-ALK variants; Non–small-cell lung cancer; Tandem atypical propeller EML domain; Tyrosine kinase inhibitor.
Publication types
-
Case Reports
-
Research Support, N.I.H., Extramural
MeSH terms
-
Adenocarcinoma of Lung / drug therapy*
-
Adenocarcinoma of Lung / genetics
-
Adenocarcinoma of Lung / pathology
-
Aged
-
Anaplastic Lymphoma Kinase / genetics*
-
Crizotinib / administration & dosage*
-
Gene Rearrangement*
-
Humans
-
Lung Neoplasms / drug therapy*
-
Lung Neoplasms / genetics
-
Lung Neoplasms / pathology
-
Male
-
Protein Kinase Inhibitors / administration & dosage*
-
Treatment Outcome
Substances
-
Protein Kinase Inhibitors
-
Crizotinib
-
ALK protein, human
-
Anaplastic Lymphoma Kinase